Microneedles for painless transdermal immunotherapeutic applications

Amani, H. and Shahbazi, M.-A. and D'Amico, C. and Fontana, F. and Abbaszadeh, S. and Santos, H.A. (2021) Microneedles for painless transdermal immunotherapeutic applications. Journal of Controlled Release, 330. pp. 185-217.

Microneedles for painless transdermal immunotherapeutic applications.pdf

Download (5MB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....


Immunotherapy has recently garnered plenty of attention to improve the clinical outcomes in the treatment of various diseases. However, owing to the dynamic nature of the immune system, this approach has often been challenged by concerns regarding the lack of adequate long-term responses in patients. The development of microneedles (MNs) has resulted in the improvement and expansion of immuno-reprogramming strategies due to the housing of high accumulation of dendritic cells, macrophages, lymphocytes, and mast cells in the dermis layer of the skin. In addition, MNs possess many outstanding properties, such as the ability for the painless traverse of the stratum corneum, minimal invasiveness, facile fabrication, excellent biocompatibility, convenient administration, and bypassing the first pass metabolism that allows direct translocation of therapeutics into the systematic circulation. These advantages make MNs excellent candidates for the delivery of immunological biomolecules to the dermal antigen-presenting cells in the skin with the aim of vaccinating or treating different diseases, such as cancer and autoimmune disorders, with minimal invasiveness and side effects. This review discusses the recent advances in engineered MNs and tackles limitations relevant to traditional immunotherapy of various hard-to-treat diseases. © 2020 Elsevier B.V.

Item Type: Article
Additional Information: cited By 2
Uncontrolled Keywords: Biocompatibility; Needles, Antigen presenting cells; Autoimmune disorder; Clinical outcome; Dendritic cells; Dynamic nature; Facile fabrication; Immunotherapeutic; Stratum corneum, Diseases, bacterial vaccine; cancer vaccine; DNA vaccine; immunomodulating agent; virus vaccine, acne; antigen presenting cell; Article; atopic dermatitis; autoimmune disease; biocompatibility; cancer immunotherapy; clinical outcome; dendritic cell; dermis; drug delivery system; first pass effect; food allergy; human; immunotherapy; insulin dependent diabetes mellitus; lymphocyte; macrophage; mast cell; nonhuman; outcome assessment; physical chemistry; priority journal; psoriasis; respiratory tract allergy; rheumatoid arthritis; stratum corneum; vaccination; wound healing
Subjects: WR Dermatology
Depositing User: eprints admin
Date Deposited: 14 Mar 2021 10:36
Last Modified: 30 Jun 2021 06:01
URI: http://eprints.iums.ac.ir/id/eprint/32930

Actions (login required)

View Item View Item